摘要
Abstract
Objective To study the clinical practice effect of initial smear-positive pulmonary tuberculosis with levofloxacin injection combined with chemotherapy in the treatment of tuberculosis. Methods 100 cases of patients with initial smear-positive pulmonary tuberculosis were selected from June 2012 to June 2013 in our hospital and were randomly divided into experimental group and control group, two groups of 50 cases. The experimental group was treated with 2HRZE/4HR scheme of adding levofloxacin dispersible tablets, the control group was treated with 2HRZE/4HR scheme, the whole course of treatment for 6 months, then gathered the sputum negative conversion rate of detection of the patient, the focus absorption rate, the improvement of the patients' symptoms, ADR and closely observe the patientsymptom after 2, 4, 6 monthes, and analyzed the clinical curative effect of the two treatment methods. Results The sputum negative conversion rate of the experimental group was significantly better than the control group, the focus absorption rate of experimental group was better than the control group, the difference between the two groups was statistically significant (P < 0.05). Conclusion The treatment of initial smear-positive pulmonary tuberculosis with levofloxacin combined with antituberculosis chemotherapy clinical effect is remarkable, and has popularization and application value.关键词
左氧氟沙星/抗结核化疗/初治涂阳肺结核Key words
Levofloxacin/Antituberculous chemotherapy/Initial smear-positive pulmonary tuberculosis分类
医药卫生
